Abstract:Background Non-smoking-related lung adenocarcinoma (LUAD) has its own characteristics. Genetic and microenvironmental differences in smoking and non-smoking LUAD patients were analyzed to elucidate the oncogenesis of non-smoking-related LUAD, which will improve our understanding of the underlying molecular mechanism and be of clinical use in the future. Methods The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) databases were used for clinical and genomic information. Various bioinformatics tools were used to analyze differences in somatic mutations, RNA and microRNA (miRNA) expression, immune infiltration, and stemness indices. GO, KEGG, and GSVA analyses were performed with R. A merged protein-protein interaction (PPI) network was constructed and analyzed. A miRNA-differentially expressed gene network was constructed with miRNet. qRT-PCR was used for validation of 4 most significantly differently expressed genes and 2 miRNAs in tumor samples obtained from 20 pairs of non-smoking and smoking patients. Results Five hundred and one patients with LUAD were obtained, including 210 in the non-smoking group and 292 in the smoking group. A total of 174 significantly altered somatic mutations were detected, including mutations in tumor protein p53 and epidermal growth factor receptor, which were downregulated in non-smoking-related LUAD. At the RNA level, 231 significantly differentially expressed genes were obtained; 124 were upregulated and 107 downregulated in the non-smoking group. GSVA analysis revealed 42 significant pathways. Other functional and enrichment analyses of somatic mutations and RNA expression levels revealed that these genes were significantly enriched in receptor activity regulation and receptor binding. Differences in microenvironments including immune infiltration (e.g., CD8+ T cells and resting mast cells) and stemness indices were also found between groups. A 79-pair interaction was found between differentially expressed genes and miRNAs, of which miR-335-5p and miR-34a-5p were located in the center. Twenty-one genes, including vitronectin, neurotensin, and neuronatin, were differentially expressed in both non-smoking LUAD patients and DMSO-treated A549 cells. And the different expression of neurotensin, neuronatin, trefoil factor family2, regenerating family member 4, miR-377-5p, miR-34a were verified with the same tendency in our own samples. Conclusions Non-smoking LUAD patients, compared to smokers, have different characteristics in terms of somatic mutation, gene, and miRNA expression and the microenvironment, indicating a diverse mechanism of oncogenesis.

Bioinformatics Analyses of the Differences Between Lung Adenocarcinoma and Squamous Cell Carcinoma Using the Cancer Genome Atlas Expression Data.

Identification of Stage-associated MicroRNAs in Lung Adenocarcinoma Based on Microarray Data

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma

Microarray Profiling of Differentially Expressed Lncrnas and Mrnas in Lung Adenocarcinomas and Bioinformatics Analysis

Identification of Differentially Expressed Genes Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma by Gene Expression Profiling

Comprehensive Analysis of Aberrantly Expressed Profiles of Lncrnas and Mirnas with Associated Cerna Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC)

Identification key genes, key miRNAs and key transcription factors of lung adenocarcinoma

Bioinformatics Analysis Of Differentially Expressed Mirnas In Non-Small Cell Lung Cancer

A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma

Identification of The Potential Signature Genes Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Genetic Analyses of Differences Between Solid and Nonsolid Predominant Lung Adenocarcinomas

Comprehensive Network Analysis Of Different Subtypes Of Molecular Disorders In Lung Cancer

Differentially Expressed Mirnas in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma.

Comprehensive Analysis of Aberrantly Expressed Microrna Profiles Reveals Potential Biomarkers of Human Lung Adenocarcinoma Progression.

Identification of microRNAs as potential biomarkers for lung adenocarcinoma using integrating genomics analysis.

Genetic and Microenvironmental Differences in Non-Smoking Lung Adenocarcinoma Patients Compared with Smoking Patients

Identification of dysregulated long non-coding RNAs/microRNAs/mRNAs in TNM I stage lung adenocarcinoma.

Identification of prognostic genes in lung adenocarcinoma immune microenvironment

Identification of Differentially Expressed Genes in Lung Adenocarcinoma Cells Using Single-Cell RNA Sequencing Not Detected Using Traditional RNA Sequencing and Microarray